ABOUT THE COMPANY
The company’s portfolio has expanded due to complex products enabling effective and convenient control of a number of most critical pathogenetic factors at the same time. New products developed by GRAND MEDICAL should increase the effectiveness of therapy for many significant urological, gynecological, neurological and gastroenterological diseases. New products are actively introduced not only to rapidly developing markets CIS but also to mature markets of Central, Western and Southern Europe and Asia. Currently, GRAND MEDICAL operates in Poland, Spain, Turkey, Romania and Albania.
GROUP INCLUDED UNDER MENTION COMPANIES
• GRAND MEDICAL GROUP SWITZERLAND
• GMG GRAND MEDICAL TURKEY
• GRAND MEDICAL POLAND
• MIQUEL Y GARRIGA S.L. SPAIN
• SETONDA S.L. SPAIN
THE COMPANY’S MISSION
Our mission is the development of new innovative medicines to cover medical needs of clinicians in special therapeutic fields enabling us to help patients all over the world to preserve their health and well-being. We believe that every person living on earth has the right for access to quality innovative medicines.
THE COMPANY’S OBJECTIVE
The company’s objective is formation of a stable international structure enabling the development of high-quality innovative products with guaranteed effective therapy for a wide range of diseases. Besides, one of the company’s goals is engagement of talented people in innovative processes and solution of existing and future health care problems.
People are the main priority for GRAND MEDICAL. Relations with the employees and clients of the company base on honesty, openness, respect and ethics. For GRAND MEDICAL, the main value is trust of its employees, business partners, doctors, pharmacists and, above all, patients.